Tag: ADC

Mergers and Acquisitions

BioNTech moves into ADCs with Duality deal

April 3, 2023

Via: Biopharma Dive

Armed with cash earned from sales of the COVID-19 vaccine it developed with Pfizer, BioNTech has been investing in cancer drug research and development — its primary focus prior to the pandemic. While BioNTech specializes in messenger RNA, it also […]

Industry, Pharma

NICE backs two new breast cancer drugs for NHS use

July 14, 2022

Via: Pharmaphorum

In a statement, the health technology assessment (HTA) organisation said that the two drugs were backed after an agreement with the two developers on pricing that will make them an option for around 3,450 NHS patients. Trodelvy (sacituzumab govitecan) can […]

Manufacturing, Research and Development

Seagen to expand, add jobs with new cancer drug factory

April 21, 2022

Via: Biopharma Dive

Formerly known as Seattle Genetics, Seagen has grown to become one of the industry’s largest biotechs, with a market value of $26 billion. Seagen’s business is built on antibody drug conjugates, or ADCs, a type of medicine that uses laboratory-engineered […]